Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
52,124,856
-
Share change
-
-987,403
-
Total reported value
-
$1,684,666,056
-
Price per share
-
$32.32
-
Number of holders
-
168
-
Value change
-
-$42,369,690
-
Number of buys
-
93
-
Number of sells
-
84
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2015
As of 30 Sep 2015,
HAEMONETICS CORP - Common Stock (HAE) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,124,856 shares.
The largest 10 holders included
VANGUARD GROUP INC, Neuberger Berman Group LLC, BlackRock Fund Advisors, WELLS FARGO & COMPANY/MN, BARROW HANLEY MEWHINNEY & STRAUSS LLC, Black Creek Investment Management Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WESTWOOD HOLDINGS GROUP INC, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
168
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.